Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 7, 2019

Navidea Biopharmaceuticals Schedules Fourth Quarter 2018 Earnings Conference Call and Business Update

Feb 28, 2019

Navidea Biopharmaceuticals Announces Extension of NYSE American Listing

Feb 1, 2019

Navidea Biopharmaceuticals Announces Decision by Ohio Supreme Court

Jan 24, 2019

Navidea Biopharmaceuticals Announces Patent Extension for Lymphoseek®

Dec 7, 2018

Navidea Biopharmaceuticals Appoints Adam Cutler to Board of Directors

Nov 29, 2018

Navidea Biopharmaceuticals Appoints Dr. Michael Rosol as Chief Medical Officer

Nov 29, 2018

Navidea Biopharmaceuticals to Present at the 11th Annual LD Micro Event 2018

Nov 28, 2018

Navidea Biopharmaceuticals Announces Presentation at the Radiological Society of North America (RSNA) 104th Scientific Assembly and Annual Meeting 2018

Nov 27, 2018

Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of Directors

Nov 26, 2018